Cargando…
MicroRNA-506-3p inhibits ovarian cancer metastasis by down-regulating the expression of EZH2
Objective: To investigate the role of miR-506-3p in ovarian cancer (OvCa) metastasis. Methods: We overexpressed miR-506-3p in OvCa cells, and cell migration and invasion capacities were assessed in vitro using Transwell assays and wound healing assay. EZH2 is a target of miR-506-3p. We overexpressed...
Autores principales: | Sun, Yue, Meng, Chao, Liu, Guoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824902/ https://www.ncbi.nlm.nih.gov/pubmed/35154460 http://dx.doi.org/10.7150/jca.66959 |
Ejemplares similares
-
MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers
por: Sun, Yue, et al.
Publicado: (2020) -
MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
por: Zhang, Yi, et al.
Publicado: (2015) -
Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2
por: Wang, Gui-Jun, et al.
Publicado: (2019) -
MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression
por: Jiashi, Wang, et al.
Publicado: (2018) -
MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2
por: Liang, Tian-Song, et al.
Publicado: (2019)